Literature DB >> 20445185

Second-generation drug-eluting coronary stents.

Richard A Lange, L David Hillis.   

Abstract

Mesh：

Substances：

Year:  2010        PMID： 20445185     DOI： 10.1056/NEJMe1001069

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  10 in total

Review 1.  [Second-generation DES : New, but also cost-effective?].

Authors:  F Müller-Riemenschneider; T Reinhold; S N Willich
Journal:  Herz       Date:  2011-05       Impact factor: 1.443

2.  Meta-analysis of randomized controlled trials on efficacy and safety of extended thienopyridine therapy after drug-eluting stent implantation.

Authors:  Wenyi Tang; James Yeh; Jian Chen; Mao Liu; Jianting Ke; Guangyi Tan; Xiufang Lin; Wei Wu
Journal:  Cardiovasc Diagn Ther       Date:  2016-10

3.  Dual antiplatelet therapy duration after the placement of a drug-eluting stent: what are the data?

Authors:  Jad Raffoul; Andrew J P Klein
Journal:  Curr Treat Options Cardiovasc Med       Date:  2015-03

4.  microRNAs Distinctively Regulate Vascular Smooth Muscle and Endothelial Cells: Functional Implications in Angiogenesis, Atherosclerosis, and In-Stent Restenosis.

Authors:  Gaetano Santulli
Journal:  Adv Exp Med Biol       Date:  2015       Impact factor: 2.622

5.  Angiographic and clinical comparison of novel Orsiro Hybrid sirolimus-eluting stents and Resolute Integrity zotarolimus-eluting stents in all-comers with coronary artery disease (ORIENT trial): study protocol for a randomized controlled trial.

Authors:  Joo Myung Lee; Sang-Don Park; Sang Yup Lim; Joon-Hyung Doh; Jin Man Cho; Ki-Seok Kim; Jang-Whan Bae; Woo-Young Chung; Tae-Jin Youn
Journal:  Trials       Date:  2013-11-20       Impact factor: 2.279

6.  Impact of body fat distribution on long-term clinical outcomes after drug-eluting stent implantation.

Authors:  Se-Jun Park; Hong-Seok Lim; Seung-Soo Sheen; Hyoung-Mo Yang; Kyoung-Woo Seo; So-Yeon Choi; Byoung-Joo Choi; Myeong-Ho Yoon; Seung-Jea Tahk
Journal:  PLoS One       Date:  2018-05-25       Impact factor: 3.240

Review 7.  Short-versus long-term dual antiplatelet therapy after second-generation drug-eluting stent implantation: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Hongqing Li; Wenqin Guo; Weiran Dai; Lang Li
Journal:  Drug Des Devel Ther       Date:  2018-06-22       Impact factor: 4.162

Review 8.  Diabetes and restenosis.

Authors:  Scott Wilson; Pasquale Mone; Urna Kansakar; Stanislovas S Jankauskas; Kwame Donkor; Ayobami Adebayo; Fahimeh Varzideh; Michael Eacobacci; Jessica Gambardella; Angela Lombardi; Gaetano Santulli
Journal:  Cardiovasc Diabetol       Date:  2022-02-14       Impact factor: 9.951

9.  Risk factors for coronary drug-eluting stent thrombosis: influence of procedural, patient, lesion, and stent related factors and dual antiplatelet therapy.

Authors:  Krishnankutty Sudhir; James B Hermiller; Joanne M Ferguson; Charles A Simonton
Journal:  ISRN Cardiol       Date:  2013-06-23

10.  Early and long-term outcomes of bioresorbable vascular scaffolds in the treatment of patients with coronary artery disease in real-world clinical practice - insights from the ZABRZE-BVS registry.

Authors:  Jacek Piegza; Piotr Desperak; Jacek Kowalczyk; Marek Gierlotka; Michał Hawranek; Piotr Chodór; Marcin Świerad; Andrzej Lekston; Zbigniew Kalarus; Mariusz Gąsior
Journal:  Postepy Kardiol Interwencyjnej       Date:  2018-12-11       Impact factor: 1.426
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.